Yo-Chuen Lin

Affiliations: 
2015-2019 Cell and Developmental Biology University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Google:
"Yo-Chuen Lin"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Peter M. Yau grad student 2015-2019 UIUC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kurniawan F, Chetlangia N, Kamran M, et al. (2022) BEND3 safeguards pluripotency by repressing differentiation-associated genes. Proceedings of the National Academy of Sciences of the United States of America. 119
Lin YC, Prasanth SG. (2021) Replication initiation: Implications in genome integrity. Dna Repair. 103: 103131
Hao Q, Zong X, Sun Q, et al. (2020) The S-phase-induced lncRNA promotes cell proliferation by controlling YAP1/Hippo signaling pathway. Elife. 9
Sun Q, Hao Q, Lin YC, et al. (2020) Antagonism between Splicing and Microprocessor complex Dictates the Serum-induced Processing of Lnc-MIRHG for Efficient Cell Cycle Re-entry. Rna (New York, N.Y.)
Hsu RYC, Lin YC, Redon C, et al. (2020) ORCA/LRWD1 Regulates Homologous Recombination at ALT-Telomeres by Modulating Heterochromatin Organization. Iscience. 23: 101038
Singh DK, Gholamalamdari O, Jadaliha M, et al. (2017) PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes. Carcinogenesis
Tsai PH, Cheng CH, Lin CY, et al. (2016) Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells. Anticancer Research. 36: 6367-6380
Che MI, Huang J, Hung JS, et al. (2014) β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. Oncotarget. 5: 3673-84
Hung JS, Huang J, Lin YC, et al. (2014) C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. Oncotarget. 5: 2096-106
See more...